Callahan Advisors LLC cut its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 14.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,248 shares of the pharmacy operator’s stock after selling 4,886 shares during the quarter. Callahan Advisors LLC’s holdings in CVS Health were worth $1,313,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the third quarter worth about $25,000. Ridgewood Investments LLC lifted its stake in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares in the last quarter. Stonebridge Financial Group LLC purchased a new stake in CVS Health during the fourth quarter valued at about $28,000. Livelsberger Financial Advisory purchased a new stake in CVS Health during the third quarter valued at about $31,000. Finally, Legacy Investment Solutions LLC purchased a new stake in CVS Health during the third quarter valued at about $31,000. 80.66% of the stock is currently owned by institutional investors.
CVS Health Trading Down 1.0 %
NYSE:CVS opened at $65.71 on Tuesday. The stock’s 50 day moving average price is $51.30 and its 200 day moving average price is $56.03. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a market capitalization of $82.68 billion, a P/E ratio of 16.68, a P/E/G ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.
CVS Health Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.05%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.
Wall Street Analyst Weigh In
A number of analysts have commented on CVS shares. Wells Fargo & Company upped their price objective on shares of CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Wolfe Research upped their price objective on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research note on Tuesday, February 11th. Royal Bank of Canada reduced their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research note on Tuesday, December 3rd. Finally, Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $70.28.
Check Out Our Latest Stock Analysis on CVS Health
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
- Five stocks we like better than CVS Health
- Where Do I Find 52-Week Highs and Lows?
- Super Micro Computer Soars 26% in a Week—More Upside Ahead?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Stocks for a Value Portfolio: Undervalued Gems to Watch
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- WeRide Stock Explodes as NVIDIA’s Investment Emerges
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.